📰 Adaptive Research News
Page 2 - Adaptive Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Adaptive Research. Real-time updates on events, politics, business and more.
October 25, 2023
The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.
October 25, 2023
Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.
October 25, 2023
Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.
October 5, 2023
/PRNewswire/ -- The Childrens Tumor Foundation (NEW YORK, NY and BRUSSELS, BELGIUM) and the Global Coalition for Adaptive Research (LARKSPUR, CA) – The...
September 25, 2023
SAN DIEGO, Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor therapies, today announced the presentation of...
September 18, 2023
SAN DIEGO, Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results...
September 5, 2023
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today
August 15, 2023
Polaris Now Enrolling in GBM AGILE, Registrational Phase 2-3 Adaptive Platform Trial for Patients with GlioblastomaPolaris lead biologic ADI-PEG 20 to be Evaluated Across Multiple International Trial SitesLARKSPUR, Calif.--(BUSINESS WIRE)--#GBMAGILE--Global Coalition for Adaptive Research (LARKSPUR, CA) and Polaris...
August 9, 2023
SAN DIEGO, Aug. 9, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President...
July 19, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...